UEMS Medicinsk speciale

Psykiatri & Neurodevelopment — Side 2

Formulation science addressing mental health: catecholaminergic modulation, ADHD, mood disorders, neuropsychological function, and the gut–brain axis as a therapeutic target.

25

dossierer

Præcisionsmikrobiom & Tarm-hjerne-aksen

Tarm-hjerne-aksen ved ADHD: Mikrobiota-medieret modulering af den dopaminerge signalvej

Udvikling af videnskabeligt validerede mikrobiom-målrettede interventioner til ADHD indebærer håndtering af udfordringer vedrørende heterogenitet i kliniske resultater og identifikation af præcise mikrobielle mekanismer. Formulering af stabile, effektive probiotika eller synbiotika med påviste kliniske fordele forbliver en væsentlig barriere.

NeuroinflammationAttention Deficit Disorder with HyperactivityDopamineSerotonin

Skræddersyet formulering tilgængelig

Har du brug for et dossier til dit molekyle?

Vores R&D-team udfører en Paid Discovery Audit og udarbejder et proprietært klinisk dossier til din specifikke aktive ingrediens eller terapeutiske target. Fuld IP-overdragelse inkluderet.

Drøft et partnerskab →← Vend tilbage til Clinical Matrix

RELATED RESOURCES

R&D Hub — All Scientific CategoriesFull library of evidence-based research covering formulation, bioavailability and clinical nutrition.EXPLORE ›Advanced Formulation Technology PlatformLiposomal, enteric and micellar encapsulation systems with AI-verified safety screening.EXPLORE ›Production Formats & MOQ ReferenceHard capsules 150K, softgels 300K, sachets 250K — connect the science to actual industrial thresholds.EXPLORE ›Physician Supplement Brand Contract ManufacturingClinician-led programmes with zero conflict of interest and full IP ownership.EXPLORE ›Paid Discovery: R&D Due Diligence EntryTransform research findings into a scoped, confidential manufacturing brief.EXPLORE ›Commercialization Intelligence HubRegulatory and market strategy intelligence for supplement brand decision-makers.EXPLORE ›